Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC3153
TNBC
Basal A
Omipalisib
PI3K
PI3K
7465.087
uM
0.04939
0.14352
-0.5310 -0.4833 0.6340 0.6243
0.9871
1.1924
HCC3153
TNBC
Basal A
Omipalisib
PI3K
PI3K
10577.087
uM
0.02859
0.16521
-0.6730 -0.7709 0.5318 0.7487
0.9909
0.9288
HCC3153
TNBC
Basal A
Omipalisib
PI3K
PI3K
7466.087
uM
0.03978
0.11243
-0.5216 -0.5276 0.6934 0.6732
0.9954
0.9127
HCC3153
TNBC
Basal A
Oxaliplatin
DNA cross-linker
DNA cross-linker
10056.021
uM
5.58260
20.4540
-0.9069 -1.0000 0.8461 0.5723
0.9822
0.8839
HCC3153
TNBC
Basal A
Oxaliplatin
DNA cross-linker
DNA cross-linker
7853.011
uM
9.18260
42.52990
-0.7134 -1.0000 0.7167 0.4650
0.9883
1.6331
HCC3153
TNBC
Basal A
Oxamflatin
HDAC
HDAC
10937.147
uM
1.66520
3.93510
-0.9591 -1.0000 1.2775 0.4482
0.9976
1.2614
HCC3153
TNBC
Basal A
PD 98059
MEK
MAPK
10937.152
uM
inf
inf
0.8382 0.8382 0.0000 0.0614
0.3121
1.2272
HCC3153
TNBC
Basal A
PD 98059
MEK
MAPK
10577.136
uM
136.76730
1000.00000
0.4353 -0.3602 0.2727 0.1740
0.7364
0.9962
HCC3153
TNBC
Basal A
PD173074
FGFR1/3
RTK
7465.1
uM
16.31040
106.92180
0.1370 -1.0000 0.5843 0.2037
0.8529
1.2603
HCC3153
TNBC
Basal A
PD173074
FGFR1/3
RTK
7466.093
uM
15.29620
32.19080
-0.0284 -1.0000 1.4765 0.1283
0.9755
0.8543
HCC3153
TNBC
Basal A
PD173074
FGFR1/3
RTK
10577.1
uM
20.79410
22.85870
-0.2781 -0.2857 4.7745 0.0752
0.9891
0.8774
HCC3153
TNBC
Basal A
PD184352
MEK
MAPK
10937.155
uM
inf
inf
0.8699 0.8699 0.0000 0.0994
0.0000
1.3142
HCC3153
TNBC
Basal A
PD184352
MEK
MAPK
10937.155
uM
inf
inf
0.8699 0.8699 0.0000 0.0994
0.0000
1.3142
HCC3153
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7466.095
uM
inf
inf
1.0039 1.0039 0.0000 -0.0104
-0.0877
0.8699
HCC3153
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7465.095
uM
inf
inf
0.8393 0.8393 0.0000 0.1223
-0.0252
1.2754
HCC3153
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7467.095
uM
inf
0.17682
0.6582 0.6600 5.0000 0.2517
0.9791
1.2671
HCC3153
TNBC
Basal A
PS-1145
IKK
NFKB
7467.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0386
-3.7264
1.2393
HCC3153
TNBC
Basal A
PS-1145
IKK
NFKB
7466.065
uM
inf
999.98670
0.8529 0.7466 0.2221 0.0649
0.5788
0.8210
HCC3153
TNBC
Basal A
PS-1145
IKK
NFKB
7465.065
uM
inf
133.16390
0.8660 0.8650 2.1441 0.0311
0.6555
1.2013
HCC3153
TNBC
Basal A
Purvalanol A
CDK1
CDK
7466.067
uM
inf
inf
0.9484 0.9484 0.0000 -0.0204
0.1276
0.9457
HCC3153
TNBC
Basal A
Purvalanol A
CDK1
CDK
7467.067
uM
261.60790
27.4740
0.5251 0.4555 1.0733 0.1070
0.9450
1.3252
HCC3153
TNBC
Basal A
QNZ
NFkB
NFKB
7466.096
uM
0.76630
0.03664
0.3984 0.4029 0.5392 0.3172
0.9597
0.9269
HCC3153
TNBC
Basal A
Ro 32-0432
PKC
PKC
10577.142
uM
inf
0.00015
0.8665 0.8748 5.0000 0.1168
0.5822
1.0584
HCC3153
TNBC
Basal A
SB-3CT
MMP2/9
MMP
10577.144
uM
inf
inf
0.9200 0.9200 0.0000 0.0282
0.2113
0.9534
HCC3153
TNBC
Basal A
SB-3CT
MMP2/9
MMP
10937.144
uM
inf
17.12360
0.8542 0.8541 4.9969 0.0238
0.6766
1.5466